Remove tag tigit
article thumbnail

Roche nabs breakthrough tag for TIGIT cancer immunotherapy

pharmaphorum

Roche’s closely-watched combination of two checkpoint inhibitors – TIGIT-targeting tiragolumab and PD-L1 drug Tecentriq – has claimed breakthrough status from the FDA. The post Roche nabs breakthrough tag for TIGIT cancer immunotherapy appeared first on.